MedPath

Effect of combined training in treatment of primary hypertensio

Not Applicable
Conditions
Primary Hypertension.
Essential (primary) hypertension
Registration Number
IRCT20190317043080N1
Lead Sponsor
The University of Birjand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
60
Inclusion Criteria

Have primary hypertension and at least one year has passed since their illness
The range of systolic blood pressure should be in the range of 140-159 mmHg and diastolic blood pressure should be in the range of 99-90 mmHg
Do not have a history of doing regular exercise training in the six months leading up to the research
Do not have any history of heart surgery
Do not have diabetes, fatty liver, hypothyroidism or hyperthyroidism, anemia and kidney disease
Do not have a history of myocardial infarction, heart attack, cardiac arrhythmia, ischemic disease, or unstable angina

Exclusion Criteria

There is a problem in the bone, muscle and joints that prevent doing exercise
The use of calcium channel blockers such as verapamil, amlodipine, diltiazem
Smoking, drug addiction and alcohol consumption

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Superoxide dismutase enzyme activity. Timepoint: At the beginning of the study (before the intervention), at the end of the study (after the intervention). Method of measurement: Calorimetric assay (superoxide dismutase kit).;Fibrinogen. Timepoint: At the beginning of the study (before the intervention), at the end of the study (after the intervention). Method of measurement: Enzyme – Linked ImmunoSorbent Assay (ELISA kit for fibrinogen).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath